AIBL’s journal articles
Below is an archive of AIBL’s refereed journal articles as available on Pubmed. This does not include abstracts, conference proceedings or other external publications.
ALL PUBLICATIONS
ALL NEWS & EVENTS
A plasma protein classifier for predicting amyloid burden for preclinical Alzheimer’s disease
Ashton NJ, Nevado-Holgado AJ, Barber IS, Lynham S, Gupta V, Chatterjee P, Goozee K, Hone E, Pedrini S, Blennow K, Schöll M, Zetterberg H, Ellis KA, Bush AI, Rowe CC, Villemagne VL, Ames D, Masters CL, Aarsland D, Powell J, Lovestone S, Martins R, Hye A (2019).
Klotho allele status is not associated with Abeta and APOE epsilon4-related cognitive decline in preclinical Alzheimer’s disease
Porter T, Burnham SC, Milicic L, Savage G, Maruff P, Lim YY, Ames D, Masters CL, Martins RN, Rainey-Smith S, Rowe CC, Salvado O, Groth D, Verdile G, Villemagne VL, Laws SM (2019).
COMT val158met is not associated with Abeta-amyloid and APOE epsilon4 related cognitive decline in cognitively normal older adults
Porter T, Burnham SC, Milicic L, Savage G, Maruff P, Sohrabi HR, Peretti M, Lim YY, Weinborn M, Ames D, Masters CL, Martins RN, Rainey-Smith S, Rowe CC, Salvado O, Groth D, Verdile G, Villemagne VL, Laws SM (2019).
Validation of a priori candidate Alzheimer’s disease SNPs with brain amyloid-beta deposition
Vacher M, Porter T, Villemagne VL, Milicic L, Peretti M, Fowler C, Martins R, Rainey-Smith S, Ames D, Masters CL, Rowe CC, Doecke JD, Laws SM (2019).
Sensitivity of a Preclinical Alzheimer’s Cognitive Composite (PACC) to amyloid beta load in preclinical Alzheimer’s disease
Bransby L, Lim YY, Ames D, Fowler C, Roberston J, Harrington K, Snyder PJ, Villemagne VL, Salvado O, Masters CL, Maruff PftARG (2019).
KIBRA is associated with accelerated cognitive decline and hippocampal atrophy in APOE epsilon4-positive cognitively normal adults with high Aβ-amyloid burden
Porter T, Burnham SC, Dore V, Savage G, Bourgeat P, Begemann K, Milicic L, Ames D, Bush AI, Maruff P, Masters CL, Rowe CC, Rainey-Smith S, Martins RN, Groth D, Verdile G, Villemagne VL, Laws SM (2018).
Amyloid burden and incident depressive symptoms in preclinical Alzheimer’s disease
Perin S, Harrington KD, Lim YY, Ellis K, Ames D, Pietrzak RH, Schembri A, Rainey-Smith S, Salvado O, Laws SM, Martins RN, Villemagne VL, Rowe CC, Masters CL, Maruff P; AIBL research group (2018).
A Polygenic Risk Score Derived From Episodic Memory Weighted Genetic Variants Is Associated With Cognitive Decline in Preclinical Alzheimer’s Disease
Porter T, Burnham SC, Savage G, Lim YY, Maruff P, Milicic L, Peretti M, Ames D, Masters CL, Martins RN, Rainey-Smith S, Rowe CC, Salvado O, Taddei K, Groth D, Verdile G, Villemagne VL, Laws SM (2018).
Utility of an Alzheimer’s Disease Risk-Weighted Polygenic Risk Score for Predicting Rates of Cognitive Decline in Preclinical Alzheimer’s Disease: A Prospective Longitudinal Study
Porter T, Burnham SC, Milicic L, Savage G, Maruff P, Lim YY, Li QX, Ames D, Masters CL, Rainey-Smith S, Rowe CC, Salvado O, Groth D, Verdile G, Villemagne VL, Laws SM, AIBL (2018).
Cognitive gene risk profile for the prediction of cognitive decline in presymptomatic Alzheimer’s disease
Porter T, Villemagne VL, Savage G, Milicic L, Ying Lim Y, Maruff P, Masters CL, Ames D, Bush AI, Martins RN, Rainey-Smith S, Rowe CC, Taddei K, Groth D, Verdile G, Burnham SC, Laws SM (2018).
Stay up to date with the latest news from the AIBL study.